Dow Up0.82% Nasdaq Up0.70%

CTI BioPharma Corp. (CTIC)

-NasdaqCM
0.46 Up 0.01(1.40%) 4:00PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2015Dec 31, 2014Dec 31, 2013
Total Revenue 16,116   60,077   34,678  
Cost of Revenue1,940  895  137  
Gross Profit 14,176   59,182   34,541  
Operating Expenses
Research Development76,627  64,596  33,624  
Selling General and Administrative54,215  58,960  42,443  
Non Recurring -  21,859   -  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss (116,666) (86,233) (41,526)
Income from Continuing Operations
Total Other Income/Expenses Net(1,993)(6,049)(998)
Earnings Before Interest And Taxes(118,659)(92,282)(42,524)
Interest Expense2,104  1,947  1,026  
Income Before Tax(120,763)(94,229)(43,550)
Income Tax Expense -   -   -  
Minority Interest1,341  862  807  
Net Income From Continuing Ops(119,422)(93,367)(42,743)
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income (119,422) (93,367) (42,743)
Preferred Stock And Other Adjustments(3,200)(2,625)(6,900)
Net Income Applicable To Common Shares (122,622) (95,992) (49,643)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.